CURRENT RECRUITING TRIALS

B3451002
A phase 2b, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of Staphylococcus aureus 4-antigen vaccine (SA4Ag) in adults undergoing elective open posterior spinal fusion procedures with multilevel instrumentation.

From clinicaltrials.gov:

The purposes of the clinical trial are to determine whether the SA4Ag vaccine can prevent postoperative Staphylococcus aureus infections in patients who are undergoing elective spinal fusion surgery, and to evaluate the safety of SA4Ag in patients who are undergoing elective spinal surgery.

More information

PATIENTS: For information on neuro-surgery clinical trials, please contact info-CRU.neuro@mcgill.ca.

UPCOMING TRIALS

to come